viewAkers Biosciences, Inc.

Akers Biosciences adds lab expert to board

Laboratory expert Dr Raza Bokhari, will join as a non-executive director

Akers makes diagnostic tests for hospitals

Akers Biosciences (LON:AKR) has added to its board with the appointment of a life science and healthcare specialist.

Laboratory expert Dr Raza Bokhari, will join as a non-executive director, the company said on Thursday.

He is currently chairman and chief executive of Parkway Clinical Laboratories, a College of American Pathologists-accredited national laboratory performing diagnostic testing procedures.

Dr Raymond Akers, co-founder and executive chairman of Akers, said: "His expertise, particularly in the fields of laboratory testing and health and wellness diagnostics - a growing area of importance for Akers Bio - will be invaluable as we continue to accelerate the commercialization of the company's rapid diagnostic assays."

Akers develops, manufactures, and supplies rapid diagnostic tests for hospital laboratories, government, military, law enforcement, on-the-job safety, doctors’ offices and home use.

Quick facts: Akers Biosciences, Inc.

Price: 14.74 USD

Market: NASDAQ
Market Cap: $1.27 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

2 days, 6 hours ago

2 min read